2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazoline-5,9-diamine

ID: ALA5185451

PubChem CID: 168283028

Max Phase: Preclinical

Molecular Formula: C13H10N6O

Molecular Weight: 266.26

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ccc2nc(N)n3nc(-c4ccco4)nc3c2c1

Standard InChI:  InChI=1S/C13H10N6O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,14H2,(H2,15,16)

Standard InChI Key:  XEZWXDNHNPESDP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    0.1816   -2.2769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9080   -1.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9359   -1.0477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2095   -0.6006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5168   -1.0197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2432   -0.5727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9697   -0.9918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9976   -1.8299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2711   -2.2490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5448   -1.8579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6960   -0.5727    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.4050    0.2095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2432    0.2654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5505   -0.4888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6623    0.9918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3270    1.7741    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9696    2.3049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6960    1.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5005    1.0756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6344   -2.3049    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  1 10  1  0
  5 10  2  0
  7 11  1  0
  4 12  2  0
 13 12  1  0
 14 13  2  0
  3 14  1  0
 13 15  1  0
 16 15  1  0
 16 17  1  0
 18 17  2  0
 15 19  2  0
 19 18  1  0
  2 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5185451

    ---

Associated Targets(non-human)

C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.26Molecular Weight (Monoisotopic): 266.0916AlogP: 1.70#Rotatable Bonds: 1
Polar Surface Area: 108.26Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.05CX LogP: 2.03CX LogD: 2.03
Aromatic Rings: 4Heavy Atoms: 20QED Weighted: 0.51Np Likeness Score: -1.67

References

1. Wesseler F, Lohmann S, Riege D, Halver J, Roth A, Pichlo C, Weber S, Takamiya M, Müller E, Ketzel J, Flegel J, Gihring A, Rastegar S, Bertrand J, Baumann U, Knippschild U, Peifer C, Sievers S, Waldmann H, Schade D..  (2022)  Phenotypic Discovery of Triazolo[1,5-c]quinazolines as a First-In-Class Bone Morphogenetic Protein Amplifier Chemotype.,  65  (22.0): [PMID:36346705] [10.1021/acs.jmedchem.2c01199]

Source